These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 8731460)
21. Investigation of auditory potentials and cognitive impairment in premenstrual syndrome. Ors CH; Karaman HIO Neurol Sci; 2018 Mar; 39(3):503-508. PubMed ID: 29305663 [TBL] [Abstract][Full Text] [Related]
22. Seasonality of symptoms in women with late luteal phase dysphoric disorder. Maskall DD; Lam RW; Misri S; Carter D; Kuan AJ; Yatham LN; Zis AP Am J Psychiatry; 1997 Oct; 154(10):1436-41. PubMed ID: 9326828 [TBL] [Abstract][Full Text] [Related]
23. Nocturnal polysomnographic sleep across the menstrual cycle in premenstrual dysphoric disorder. Shechter A; Lespérance P; Ng Ying Kin NM; Boivin DB Sleep Med; 2012 Sep; 13(8):1071-8. PubMed ID: 22749440 [TBL] [Abstract][Full Text] [Related]
24. Menstrual cycle effects on amygdala reactivity to emotional stimulation in premenstrual dysphoric disorder. Gingnell M; Morell A; Bannbers E; Wikström J; Sundström Poromaa I Horm Behav; 2012 Sep; 62(4):400-6. PubMed ID: 22814368 [TBL] [Abstract][Full Text] [Related]
25. The effect of premenstrual dysphoric disorder and menstrual cycle phase on brain activity during response inhibition. Bannbers E; Gingnell M; Engman J; Morell A; Comasco E; Kask K; Garavan H; Wikström J; Sundström Poromaa I J Affect Disord; 2012 Dec; 142(1-3):347-50. PubMed ID: 22840469 [TBL] [Abstract][Full Text] [Related]
26. Premenstrual syndrome is associated with an altered spontaneous electroencephalographic delta/beta power ratio across the menstrual cycle. Hou L; Chen L; Zhou R Int J Psychophysiol; 2022 Nov; 181():64-72. PubMed ID: 36029920 [TBL] [Abstract][Full Text] [Related]
27. Plasma melatonin circadian rhythms during the menstrual cycle and after light therapy in premenstrual dysphoric disorder and normal control subjects. Parry BL; Berga SL; Mostofi N; Klauber MR; Resnick A J Biol Rhythms; 1997 Feb; 12(1):47-64. PubMed ID: 9104690 [TBL] [Abstract][Full Text] [Related]
28. Neuroendocrine effects of light therapy in late luteal phase dysphoric disorder. Parry BL; Hauger R; Lin E; Le Veau B; Mostofi N; Clopton PL; Gillin JC Biol Psychiatry; 1994 Sep; 36(6):356-64. PubMed ID: 7803596 [TBL] [Abstract][Full Text] [Related]
29. Light therapy of late luteal phase dysphoric disorder: an extended study. Parry BL; Mahan AM; Mostofi N; Klauber MR; Lew GS; Gillin JC Am J Psychiatry; 1993 Sep; 150(9):1417-9. PubMed ID: 8352356 [TBL] [Abstract][Full Text] [Related]
30. Patients with premenstrual dysphoric disorder have increased startle modulation during anticipation in the late luteal phase period in comparison to control subjects. Bannbers E; Kask K; Wikström J; Risbrough V; Poromaa IS Psychoneuroendocrinology; 2011 Sep; 36(8):1184-92. PubMed ID: 21435793 [TBL] [Abstract][Full Text] [Related]
31. [Characteristics of the functional state of the central nervous system in women during the menstrual cycle and in premenstrual syndrome]. Tkachenko NM; Smetnik VP; Il'ina EM Akush Ginekol (Mosk); 1991 Oct; (10):52-6. PubMed ID: 1789327 [TBL] [Abstract][Full Text] [Related]
32. Mood, neuropsychological function and cognitions in premenstrual dysphoric disorder. Man MS; MacMillan I; Scott J; Young AH Psychol Med; 1999 May; 29(3):727-33. PubMed ID: 10405094 [TBL] [Abstract][Full Text] [Related]
33. Late luteal phase dysphoric disorder in 670 women evaluated for premenstrual complaints. Hurt SW; Schnurr PP; Severino SK; Freeman EW; Gise LH; Rivera-Tovar A; Steege JF Am J Psychiatry; 1992 Apr; 149(4):525-30. PubMed ID: 1554039 [TBL] [Abstract][Full Text] [Related]
34. Cognitive flexibility, reaction time, and attention in women with premenstrual dysphoric disorder. Morgan M; Rapkin A J Gend Specif Med; 2002; 5(3):28-36. PubMed ID: 12078060 [TBL] [Abstract][Full Text] [Related]
35. Sex hormones modulate neurophysiological correlates of visual temporal attention. Kranczioch C; Lindig A; Hausmann M Neuropsychologia; 2016 Oct; 91():86-98. PubMed ID: 27503768 [TBL] [Abstract][Full Text] [Related]
36. Lower insulin-like growth factor-1 concentrations in women with premenstrual dysphoric disorder. Thys-Jacobs S; McMahon D; Bilezikian JP Am J Obstet Gynecol; 2008 May; 198(5):506.e1-8. PubMed ID: 18199422 [TBL] [Abstract][Full Text] [Related]
37. Sex differences in extinction to negative stimuli: Event-related brain potentials. Sun N; Lu H; Qu C Medicine (Baltimore); 2018 Apr; 97(17):e0503. PubMed ID: 29703014 [TBL] [Abstract][Full Text] [Related]
38. Ramifications of late luteal phase dysphoric disorder diagnosis. Cibulas BK; Howell C Issues Ment Health Nurs; 1995; 16(1):79-86. PubMed ID: 7706059 [TBL] [Abstract][Full Text] [Related]
39. Anxiety and rumination moderate menstrual cycle effects on mood in daily life. Welz A; Huffziger S; Reinhard I; Alpers GW; Ebner-Priemer U; Kuehner C Women Health; 2016 Jul; 56(5):540-60. PubMed ID: 26496479 [TBL] [Abstract][Full Text] [Related]
40. Blunted serotonin response to fenfluramine challenge in premenstrual dysphoric disorder. FitzGerald M; Malone KM; Li S; Harrison WM; McBride PA; Endicott J; Cooper T; Mann JJ Am J Psychiatry; 1997 Apr; 154(4):556-8. PubMed ID: 9090347 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]